We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT icon
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QLYS icon
201
Qualys
QLYS
$6.27B
$2.85M 0.07%
111,105
+14,580
+15% +$332K
2013 Q2
4 quarters
CYBX
202
DELISTED
CYBERONICS INC
CYBX
$2.84M 0.07%
45,425
+75
+0.2% +$4.57K
2013 Q2
4 quarters
WDAY icon
203
Workday
WDAY
$45.9B
$2.72M 0.06%
30,235
-45
-0.1% -$3.54K
2013 Q2
4 quarters
KKD
204
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$2.66M 0.06%
166,685
+10,035
+6% +$174K
2014 Q1
1 quarter
ECHO icon
205
DELISTED
Echo Global Logistics, Inc.
ECHO
$2.66M 0.06%
138,875
-475
-0.3% -$8.71K
2013 Q2
4 quarters
THOR icon
206
DELISTED
THORATEC CORPORATION
THOR
$2.64M 0.06%
75,670
-95
-0.1% -$3.17K
2013 Q2
4 quarters
GBCI icon
207
Glacier Bancorp
GBCI
$5.69B
$2.44M 0.06%
85,805
+215
+0.3% +$5.79K
2013 Q2
4 quarters
GNC
208
DELISTED
GNC Holdings, Inc.
GNC
$2.41M 0.06%
70,785
-4,125
-6% -$164K
2013 Q2
4 quarters
XPO icon
209
XPO
XPO
$21.8B
$2.31M 0.05%
+233,639
New +$2.13M
2014 Q2
0 quarters
JACK icon
210
Jack in the Box
JACK
$236M
$2.27M 0.05%
37,875
+20
+0.1% +$1.15K
2014 Q1
1 quarter
EAT icon
211
Brinker International
EAT
$8.56B
$2.21M 0.05%
45,400
-15,075
-25% -$756K
2013 Q2
4 quarters
PODD icon
212
Insulet
PODD
$9.8B
$2.18M 0.05%
54,985
+25,415
+86% +$977K
2013 Q2
4 quarters
PANW icon
213
Palo Alto Networks
PANW
$281B
$2.12M 0.05%
151,530
+90
+0.1% +$1.05K
2013 Q2
4 quarters
TECH icon
214
Bio-Techne
TECH
$11.4B
$1.87M 0.04%
80,700
-100
-0.1% -$2.21K
2013 Q3
3 quarters
VSI
215
DELISTED
Vitamin Shoppe Inc.
VSI
$1.85M 0.04%
42,925
-200
-0.5% -$8.99K
2013 Q4
2 quarters
SCOR icon
216
Comscore
SCOR
$54.1M
$1.77M 0.04%
2,500
– –
2013 Q2
4 quarters
WDR
217
DELISTED
Waddell & Reed Financial, Inc.
WDR
$1.58M 0.04%
25,220
-10,195
-29% -$660K
2013 Q2
4 quarters
QCOM icon
218
Qualcomm
QCOM
$185B
$1.19M 0.03%
15,070
– –
2013 Q2
4 quarters
EMC icon
219
DELISTED
EMC CORPORATION
EMC
$932K 0.02%
35,400
– –
2013 Q2
4 quarters
DXCM icon
220
DexCom
DXCM
$32.5B
$892K 0.02%
90,000
– –
2013 Q2
4 quarters
TRV icon
221
Travelers Companies
TRV
$80.8B
$760K 0.02%
8,085
-500
-6% -$45.6K
2013 Q2
4 quarters
CNA icon
222
CNA Financial
CNA
$12.9B
$723K 0.02%
17,900
– –
2013 Q4
2 quarters
PEP icon
223
PepsiCo
PEP
$178B
$670K 0.02%
7,500
– –
2013 Q2
4 quarters
SYK icon
224
Stryker
SYK
$113B
$657K 0.02%
7,800
-126,910
-94% -$10.4M
2013 Q2
4 quarters
COR icon
225
Cencora
COR
$65.1B
$552K 0.01%
7,600
– –
2013 Q2
4 quarters
7 8
9
10 11

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.